You have 9 free searches left this month | for more free features.

City

Bratislava (1)

Bucharest (1)

Munich (1)

Condition

Advanced Liver Fibrosis (1)

Glomerulonephritis Rapidly Progressive (1)

Liver Cirrhosis (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Alentis Therapeutics AG (2)

Collaborator

Intervention

ale.f02 (2)

placebo (2)

cyclophosphamid (1)

glucocorticoid (1)

immunosuppressive agents (1)

rituximab (1)

Study Documents

Intervention Type

drug (2)

biological (1)

Funder Type

Industry (2)

Study Type

Interventional (2)

ale.f02

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Glomerulonephritis Rapidly Progressive Trial (ALE.F02, Rituximab, GlucoCorticoid)

Not yet recruiting

Glomerulonephritis Rapidly Progressive

ALE.F02
+5 more

(no location specified)

Sep 14, 2023

Advanced Liver Fibrosis, Liver Cirrhosis Trial in Munich, Bucharest, Bratislava (ALE.F02, Placebo)

Recruiting

Advanced Liver Fibrosis
Liver Cirrhosis

ALE.F02
Placebo

Munich, Germany
+2 more

Jul 10, 2023